YASHONSE11 February 2025

Yasho Industries Limited has informed the Exchange about Investor Presentation

Yasho Industries Limited

Date: February 11, 2025

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001.

Scrip Code: 541167

Dear Sir/ Madam,

To, National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051.

Symbol: YASHO

Sub: Investor Presentation for Q3FY25

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Investor’s Presentation for Q3FY25.

The said Investor’s Presentation will be simultaneously posted on the Company’s website at www.yashoindustries.com

We request you to kindly take the same on record.

Thanking You,

For Yasho Industries Limited

Rupali Verma (Company Secretary & Compliance Officer) Membership No. A42923

Encl: As above

YASHO INDUSTRIES LIMITED REGISTERED OFFICE: Office No. 101/102, Peninsula Heights, C.D Barfiwala Marg, Juhu lane, Andheri (West), Mumbai – 400058, India TEL: +91 22 62510100; FAX: +91 22 62510199; E-Mail: info@yashoindustries.com; CIN No: L74110MH1985PLC037900

INVESTOR PRESENTATION

February - 2025

Safe Harbor

This presentation and the accompanying slides (the “Presentation”), which have been prepared by Yasho Industries Limited (the “Company”), have been prepared solely for

information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in

connection with any contract or binding commitment what so ever. No offering of securities of the Company will be made except by means of a statutory offering document

containing detailed information about the Company.

This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or

warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation.

This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission

from, this Presentation is expressly excluded.

Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively

forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and

assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various

international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future

levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its

exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results

expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking

statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third party

statements and projections.

2

COMPANY OVERVIEW

Business Overview

Leading specialty and performance chemicals manufacturer

Yasho Industries is a pioneer in specialty and fine chemicals manufacturing. Incorporated in 1985 by Mr. Vinod Jhaveri. Equipped with a dedicated research and development centre and state-of the-art manufacturing facilities, we manufacture 142 products across five business verticals - Food Antioxidants, Aroma Chemicals, Rubber Chemicals, Lubricant Additives and Specialty Chemicals. Our diverse product portfolio helps us serve a dynamic and far-reaching customer base across the world including the United States of America (USA), Europe, Asia, and the Middle East, securing more than 60% of revenue from exports.

2

142

50+

2K+

32.5K

2

820+

Business Categories

Total product (All Developed in house)

Countries of presence

Customers

Manufacturing capacity (MT)

R & D centres

Employees (incl 30 R&D personnel)

4

Board of Directors

MR. VINOD JHAVERI

Chairman & Executive Director

MR. PARAG JHAVERI

Managing Director & CEO

MR. YAYESH JHAVERI

Whole Time Director

MR. ANURAG SURANA

MR. U R BHAT

Non-Executive Independent Director

Non-Executive Independent Director

DR. PRAKASH BHATE

Non-Executive Independent Director

MRS. SUDHA NAVANDAR Non-Executive Independent Director

5

Diversified portfolio of over 142 products

Consumer Division

Industrial Division

Applications

Applications

o Flavours and fragrances; personal care products - cosmetics &

toiletries

o Agro chemicals & Pharmaceutical products o Oral care preparations o Edible oil, Confectioneries & food stuff, Animal feed, Vitamin premix,

Nutraceutical

o Tyres, Automobile components, Conveyor belts, surgical gloves,

latex gloves, condoms, balloons

o Hydraulic, turbine, engine & gear oils, metal working fluids &

greases

o Stabilisers for acrylics, printing inks/coating, UPR resins and fibre

composite resins

Manufacturing Capabilities

Total Manufacturing Capability

32,500 MT

VAPI 12,500 MT

PAKHAJAN 20,000 MT

Research & Development

Research & Development

Quality Control

As the cornerstone of our business, R&D is led by our promoters with active contribution and guidance

We are working on process improvements and new products which align with our business portfolio

Recently, we have upgraded our R&D facility and now have more than 30 chemists contributing actively

Several projects are in various stages of development, and we are confident that this will help us to achieve our future growth

Research & Development & Quality Control is our core strength. YIL continues to invest in R&D and to ensure sustainable operations throughout its facilities

technological upgradation

Our In-house testing facility & the state-of- the-art laboratory uses modern quality control methods and sophisticated instrumentation such as: •

AAS(Atomic Absorption Spectrophotometer) CHNS Analyzer Differential Scanning Calorimeter (DSC) FTIR (Fourier Transforms Infrared Spectrophotometer) GC (Gas Chromatography) HPLC (High-Performance Liquid Chromatography) UV Spectrophotometer

• • •

• •

Certifications & Accreditation

ISO Certification

FSSC 22000 Certification

FSSAI Certification

NSF Certified

STAR KOSHER Certification

FAMIQS Certification

ecovadis Certified

HALAL Certification

8

Q3 & 9M FY25 Results Highlights

Consolidated Income Statement – Q3FY25 and 9MFY25

(INR in Lac)

10

Particulars Q3 FY25Q3 FY24Y-o-YQ2 FY259 M FY259 M FY24Y-o-YFY 24Revenue from Operations14,89113,00214.5%16,390-9%48,56842,12715.3%59,356Other Income64346345604737741Total Revenue14,95613,34816,73549,17342,86460,097Cost of Material Consumed11,9268,70211,96035,38725,94534,406Change in Inventories of Finished goods & Work in Progress-3,787-766-3,010-6,9311,2003,605Total Material Consumed8,1397,9368,95028,45627,14538,011Gross Profit6,8165,4127,78520,71715,71922,086Gross Profit Margin (%)45.6%40.5%46.5%42.1%36.7%36.8%Employee Expenses 1,6251,0631,6134,7673,1274,316Other Expenses 2,4391,7593,0247,6805,0167,049EBITDA 2,7522,5906.3%3,148-12.6%8,2697,5769.2%10,722EBITDA Margin (%) 18.4%19.4%18.8%16.8%17.7%17.8%Depreciation 13013911235370811661,562EBIT1,4512,1991,9124,5616,410-28.8%9,159EBIT Margin (%)9.7%16.5%11.4%9.3%15.0%15.2%Finance Cost 16383551423446210401,487Profit before Tax-1861,843490995,370-98.2%7,673Profit before Tax(%)-1.2%13.8%2.9%0.2%12.5%12.8%Tax -10548954-913711,879Profit After Tax-811,3544361083,999-97.3%5,795PAT Margin (%) -0.5%10.1%2.6%0.2%9.3%9.6%EPS -0.7712.973.820.7935.0850.25 Management Commentary on Results –Q3FY25 and 9MFY25

Highlights of Q3FY25 and 9MFY25:

❖ Volumes have increased 8% for Q3FY25 and 18% for 9MFY25

❖ Operating margins have improved due to better product mix and improved efficiencies.

Outlook:

❖ We are confident that the new plant will start to operate at 50% utilization starting March 2025

❖ Product prices appear to have bottomed out and there is a strong industry-wide confidence that prices

are expected to go up from here on

❖ Our focus remains on safeguarding EBITDA margins through an optimized product mix and effective

cost management

11

Results Highlights (Q3FY25 and 9MFY25)

Total Revenue

EBITDA

42,864

49,173

7,576

8,269

(INR in Lac)

PAT

3,999

13,348

16,735

14,956

2,590

3,148

2,752

1,354

490

-81

102

Q3 FY24

Q2 FY25

Q3 FY25

9MFY24

9MFY25

Q3 FY24 Q2 FY25 Q3 FY25

9MFY24

9MFY25

Q3 FY24

Q2 FY25

Q3 FY25

9MFY24

9MFY25

Gross Margin (%)

EBITDA Margin (%)

PAT Margin (%)

40.5%

46.5%

45.6%

36.7%

42.1%

19.4%

18.8%

18.4% 17.7%

10.1%

9.3%

16.8%

2.9%

-0.5%

0.2%

Q3 FY24 Q2 FY25 Q3 FY25

9MFY24

9MFY25

Q3 FY24 Q2 FY25 Q3 FY25

9MFY24

9MFY25

Q3 FY24 Q2 FY25 Q3 FY25

9MFY24

9MFY25

12

Results Highlights (Q3FY25 and 9MFY25)

Category-wise Revenue Breakup

Geography-wise Revenue Breakup

Industrial Chemicals

Consumer Chemicals

International

Domestic

Q3FY25

11,791

3,108

Q3FY25

9,821

5,077

Q3FY24

11,350

1,666

Q3FY24

8,140

4,876

Category-wise Revenue Breakup

Geography-wise Revenue Breakup

Industrial Chemicals

Consumer Chemicals

International

Domestic

9MFY25

39,474

8,835

9MFY25

30,926

17,383

9MFY24

35,065

6,662

9MFY24

25,983

15,745

13

Financial Performance

Total Revenue (Lac)

62,299

68,259

60,097

Gross Profit

26,738

23,376

22,086

36,952

30,028

13,586

11,179

FY20

FY21

FY22

FY23

FY24

FY20

FY21

FY22

FY23

FY24

EBITDA (Rs. lac) & EBITDA Margin

PAT (Rs. Lac) & PAT Margin

14.4%

16.4%

16.9%

18.7%

17.8%

4.0%

5.9%

8.5%

9.9%

9.6%

12,602

10,721

10,330

5,909

4,179

6,787

5,794

5,229

2,148

1,199

FY20

FY21

FY22

FY23

FY24

FY20

FY21

FY22

FY23

FY24

14

Financial Performance

ROCE (%)

32.11

34.16

25.10

24.63

20.75

12.87

ROE (%)

Debt / Equity (x)

27.21

30.21

28.52

19.66

2.70

2.00

1.90

1.00

1.30

FY20

FY21

FY22

FY23

FY24

FY20

FY21

FY22

FY23

FY24

FY20

FY21

FY22

FY23

FY24

Fixed Asset Turnover (x)

Net Working Capital Days

4.06

3.77

4.94

4.40

3.65

141

122

122

91

95

Cash Flow from Operations (pre-tax)

INR in Lac

11,147

3,013

3,901

3,622

5,785

FY20

FY21

FY22

FY23

FY24

FY20

FY21

FY22

FY23

FY24

FY20

FY21

FY22

FY23

FY24

15

Shareholders Information

Stock Information (as on 11th February, 2025)

Market Capitalization (₹)

Shares Outstanding

Free Float

Symbol BSE / NSE

Stock Performance Chart

(As on 31st December 2024)

Shareholding Pattern (%)

1.41%

0.28%

2,286

11.4 mn.

640 crs

541167 / YASHO

26.38%

71.92%

Promoters

Public

FII

DII

Mr. Deepak Kaku Chief Financial Officer

deepak@yashoindustries.com

www.yashoindustries.com

deepak@yashoindustries.com www.yashoindustries.com

CIN – L74110MH1985PLC037900

Investor Relations:

bhavya.shah@in.mpms.mufg.com

Mr. Bhavya Shah bhavya.shah@in.mpms.mufg.com +91 80827 48577

masoom.rateria@in.mpms.mufg.com

Ms. Masoom Rateria masoom.rateria@in.mpms.mufg.com +91 98332 51393

541167

YASHO

YASHO:IN

YASO:NS

← All TranscriptsYASHO Stock Page →